| # | Drug | Count |
|---|---|---|
| 0 | VANDETANIB | 10 |
| 1 | LEVOTHYROXINE SODIUM | 3 |
| 2 | ALPRAZOLAM | 2 |
| 3 | ACETAMINOPHEN | 1 |
| 4 | ACETAMINOPHEN 500MG | 1 |
| 5 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 1 |
| 6 | ALEMTUZUMAB | 1 |
| 7 | AMLODIPINE | 1 |
| 8 | ANTACID | 1 |
| 9 | BEVACIZUMAB | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | VANDETANIB | 10 | 0.0055 |
| 1 | PRALSETINIB | 1 | 0.0005 |
| 2 | PASIREOTIDE | 1 | 0.0004 |
| 3 | CABERGOLINE | 1 | 0.0002 |
| 4 | ALEMTUZUMAB | 1 | 0.0001 |
| 5 | TAMSULOSIN HYDROCHLORIDE | 1 | 0.0000 |
| 6 | ROSUVASTATIN CALCIUM | 1 | 0.0000 |
| 7 | LINEZOLID | 1 | 0.0000 |
| 8 | OCTREOTIDE ACETATE | 1 | 0.0000 |
| 9 | THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 2 | Oxazolidinone Antibacterial [EPC] | 1 | 0.0000 |
| 3 | Kinase Inhibitor [EPC] | 12 | 0.0000 |
| 4 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 2 | 0.0000 |
| 7 | Calcium [EPC] | 1 | 0.0000 |
| 8 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 1 | 0.0000 |
| 9 | RANK Ligand Inhibitor [EPC] | 1 | 0.0000 |